20 Firstfield Road
Gaithersburg , MD 20878
Gaithersburg , MD 20878
News
-
Novavax soared 124% to $10.02 after the company announced a multi-billion-dollar deal with Sanofi to co-commercialize its COVID vaccine starting as early as 2025.
Sanofi agreed to pay Novavax an upfront licensing fee of $500 million and an additional fee of $700 million based on reaching certain milestones.
May 10, 2024
Executive/
Director
Links
Price
- Last Close
-
$ 8.77
$ -0.29 -3.2 %
Dec 10, 2024
- 52-Week High/Low
- $21.24 - $3.76
- YTD
- 82.6%
- Trading Volume
- 93,837
- Market Cap Full
- $ 1B
- Shares Outstanding
-
118.8M
Oct 31, 2023
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 39.5% | -38.5% | 1.6% | 69.4% | -70.1% | -5% | 62.6% | -48.5% | -32.6% | -0.4% |
| Q2 | 34.7% | 40.9% | -10.2% | -37.1% | 1000% | 4% | 17.1% | -30.2% | 7.2% | -2.6% |
| Q3 | -36.5% | -71.4% | -0.9% | 41.4% | -4.2% | 8% | -1.5% | -64.6% | -2.6% | - |
| Q4 | 18.7% | -39.4% | 6% | -1.1% | -28.6% | 2.9% | -31.6% | -43.5% | -32.3% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -16.7% | 23.5% | -3.2% | -5.2% | - | - | - | - | - | - | - | - |
| 2023 | 6.1% | -15.1% | -25.2% | 10.7% | 5% | -7.7% | 24.9% | -13.8% | -9.5% | -8% | -17.4% | -12.7% |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16% | 41% | -85% | -2% | 48% | 116% | 2702% | 28% | -93% | -53% | 83% |
Earnings
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Q1 | 0.10 | 0.29 | 0.16 | -0.14 | -0.11 | -0.58 | -3.05 | 2.56 | -3.41 |
| Q2 | 0.08 | 0.29 | 0.16 | -0.12 | -1.69 | -0.3 | -4.75 | -6.53 | 0.58 |
| Q3 | 0.12 | 0.24 | 0.15 | -0.12 | -0.74 | -3.21 | -4.31 | -2.15 | -1.26 |
| Q4 | 0.29 | 0.21 | 0.16 | -0.12 | -0.97 | -3.18 | -11.33 | -2.30 | - |
| A | 0.6 | 1 | 0.6 | -0.5 | -5.5 | -7.3 | -23.4 | -8.4 | -4.09 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Mar | - | 441.3 | 51.5 | 73.9 | 76.3 | 86.2 |
| Jun | 381.7 | 469.5 | 58 | 74.1 | 78.1 | 86.3 |
| Sep | 382.6 | 23.9 | 61.3 | 74.5 | 78.2 | 94.4 |
| Dec | 382.9 | 26.6 | 63.7 | 75.6 | 78.5 | 118.8 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Management | ||||||||||||||||||
| Inventory / Stock Turnover | 24.4 | - | - | - | - | |||||||||||||
| Fixed Asset Turnover | 6.2 | 4 | 2.5 | 1 | 1.1 | |||||||||||||
| Total Asset Turnover | 0.9 | 0.4 | 0.3 | 0.1 | 0.2 | |||||||||||||
| Leverage | ||||||||||||||||||
| Debt Ratio | - | - | - | - | - | |||||||||||||
| Debt – Equity Ratio | - | - | - | - | - | |||||||||||||
| Interest Coverage | -49.6 | -29.6 | -417 | -10.1 | -15.8 | |||||||||||||
| Equity multiplier | -0.5 | -0.8 | 0.3 | -0.1 | -0.2 | |||||||||||||